BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 20433277)

  • 1. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article.
    Loh Y; Duckwiler GR;
    J Neurosurg; 2010 Oct; 113(4):733-41. PubMed ID: 20433277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times.
    Velat GJ; Reavey-Cantwell JF; Sistrom C; Smullen D; Fautheree GL; Whiting J; Lewis SB; Mericle RA; Firment CS; Hoh BL
    Neurosurgery; 2008 Jul; 63(1 Suppl 1):ONS73-8; discussion ONS78-80. PubMed ID: 18728607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).
    Duffner F; Ritz R; Bornemann A; Freudenstein D; Wiendl H; Siekmann R
    Clin Neuropathol; 2002; 21(1):13-7. PubMed ID: 11846039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurological morbidity and mortality associated with the endovascular treatment of cerebral arteriovenous malformations before and during the Onyx era.
    Crowley RW; Ducruet AF; Kalani MY; Kim LJ; Albuquerque FC; McDougall CG
    J Neurosurg; 2015 Jun; 122(6):1492-7. PubMed ID: 25816081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative embolization of intracranial arteriovenous malformations with Onyx.
    Weber W; Kis B; Siekmann R; Jans P; Laumer R; Kühne D
    Neurosurgery; 2007 Aug; 61(2):244-52; discussion 252-4. PubMed ID: 17762736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization: a case-control study.
    Lee CC; Chen CJ; Ball B; Schlesinger D; Xu Z; Yen CP; Sheehan J
    J Neurosurg; 2015 Jul; 123(1):126-35. PubMed ID: 25658780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation.
    Natarajan SK; Born D; Ghodke B; Britz GW; Sekhar LN
    J Neurosurg; 2009 Jul; 111(1):105-13. PubMed ID: 19326974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemorrhage risk after partial endovascular NBCA and ONYX embolization for brain arteriovenous malformation.
    Lv X; Wu Z; Li Y; Yang X; Jiang C
    Neurol Res; 2012 Jul; 34(6):552-6. PubMed ID: 22663933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances.
    Natarajan SK; Ghodke B; Britz GW; Born DE; Sekhar LN
    Neurosurgery; 2008 Jun; 62(6):1213-25; discussion 1225-6. PubMed ID: 18824988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complication risk of endovascular embolization for cerebral arteriovenous malformation.
    Lv X; Wu Z; Jiang C; Li Y; Yang X; Zhang Y; Zhang N
    Eur J Radiol; 2011 Dec; 80(3):776-9. PubMed ID: 20950972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis.
    Elsenousi A; Aletich VA; Alaraj A
    J Neurointerv Surg; 2016 Mar; 8(3):265-72. PubMed ID: 25540177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liquid embolic agents on Gamma Knife surgery dosimetry for arteriovenous malformations. Clinical article.
    Mamalui-Hunter M; Jiang T; Rich KM; Derdeyn CP; Drzymala RE
    J Neurosurg; 2011 Aug; 115(2):364-70. PubMed ID: 21495824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Onyx versus nBCA and coils in the treatment of intracranial dural arteriovenous fistulas.
    Choo DM; Shankar JJ
    Interv Neuroradiol; 2016 Apr; 22(2):212-6. PubMed ID: 26748082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas.
    Flores BC; See AP; Weiner GM; Jankowitz BT; Ducruet AF; Albuquerque FC
    J Neurosurg; 2018 Mar; 130(3):963-971. PubMed ID: 29570006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolization of cerebral arteriovenous malformations with n-butyl-2-cyanoacrylate.
    Liu HM; Huang YC; Wang YH
    J Formos Med Assoc; 2000 Dec; 99(12):906-13. PubMed ID: 11155743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of brain AVMs with use of Onyx embolization followed by radiosurgery.
    Pierot L; Kadziolka K; Litré F; Rousseaux P
    AJNR Am J Neuroradiol; 2013 Jul; 34(7):1395-400. PubMed ID: 23391837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
    Rabinov JD; Yoo AJ; Ogilvy CS; Carter BS; Hirsch JA
    J Neurointerv Surg; 2013 Jul; 5(4):306-10. PubMed ID: 22550096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine.
    Akin ED; Perkins E; Ross IB
    J Neurosurg; 2003 Feb; 98(2):366-70. PubMed ID: 12593624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onyx embolization for the treatment of brain arteriovenous malformations.
    Xu F; Ni W; Liao Y; Gu Y; Xu B; Leng B; Song D
    Acta Neurochir (Wien); 2011 Apr; 153(4):869-78. PubMed ID: 21046174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracerebral hemorrhage following endovascular embolization of brain arteriovenous malformation with a combination of Onyx and n-butyl cyanoacrylate: a case report.
    Lee KW; Lin YC; Lo CP; Liu CC
    Clin Imaging; 2012; 36(4):375-8. PubMed ID: 22726978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.